Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vaginal Bacteria and Proinflammatory Host Immune Mediators as Biomarkers of Human Immunodeficiency Virus Acquisition Risk Among African Women.
Srinivasan S, Richardson BA, Wallis JM, Fiedler TL, Strenk SM, Hoffman NG, Proll S, Chirenje ZM, Livant EW, Fredricks DN, Hillier SL, Marrazzo JM. Srinivasan S, et al. Among authors: hillier sl. J Infect Dis. 2024 Dec 16;230(6):1444-1455. doi: 10.1093/infdis/jiae406. J Infect Dis. 2024. PMID: 39248500 Clinical Trial.
Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial.
Dezzutti CS, Richardson BA, Marrazzo JM, Tugetman J, Ramjee G, Taha T, Chirenje ZM, Abdool Karim SS, Hillier SL, Herold BC; MTN Biomedical Sciences Working Group; HPTN 035 Protocol Team. Dezzutti CS, et al. Among authors: hillier sl. J Infect Dis. 2012 Dec 15;206(12):1931-5. doi: 10.1093/infdis/jis555. Epub 2012 Sep 10. J Infect Dis. 2012. PMID: 22966121 Free PMC article.
Population-Level Correlation Between Incidence of Curable Sexually Transmitted Infections and Human Immunodeficiency Virus (HIV)-1 Among African Women Participating in HIV-1 Pre-Exposure Prophylaxis Trials.
Hunidzarira P, Brown ER, Chirenje ZM, Hillier SL, Marrazzo JM, Palanee-Phillips T, Kiweewa FM, Baeten JM; MTN-003/VOICE and MTN-020/ASPIRE Study Teams. Hunidzarira P, et al. Among authors: hillier sl. J Infect Dis. 2022 Sep 21;226(6):1069-1074. doi: 10.1093/infdis/jiac269. J Infect Dis. 2022. PMID: 35763413 Free PMC article. Clinical Trial.
Use of nonoxynol-9 and changes in vaginal lactobacilli.
Richardson BA, Martin HL Jr, Stevens CE, Hillier SL, Mwatha AK, Chohan BH, Nyange PM, Mandaliya K, Ndinya-Achola J, Kreiss JK. Richardson BA, et al. Among authors: hillier sl. J Infect Dis. 1998 Aug;178(2):441-5. doi: 10.1086/515636. J Infect Dis. 1998. PMID: 9697724 Clinical Trial.
Risk factors for cervicitis among women with bacterial vaginosis.
Marrazzo JM, Wiesenfeld HC, Murray PJ, Busse B, Meyn L, Krohn M, Hillier SL. Marrazzo JM, et al. Among authors: hillier sl. J Infect Dis. 2006 Mar 1;193(5):617-24. doi: 10.1086/500149. Epub 2006 Feb 2. J Infect Dis. 2006. PMID: 16453256
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L, Hendrix CW, Dai JY, Ganesh S, Mkhize B, Taljaard M, Parikh UM, Piper J, Mâsse B, Grossman C, Rooney J, Schwartz JL, Watts H, Marzinke MA, Hillier SL, McGowan IM, Chirenje ZM; VOICE Study Team. Marrazzo JM, et al. Among authors: hillier sl. N Engl J Med. 2015 Feb 5;372(6):509-18. doi: 10.1056/NEJMoa1402269. N Engl J Med. 2015. PMID: 25651245 Free PMC article. Clinical Trial.
402 results